Kinase inhibitor through drugs like at-7519,SU-5402

21.04.2011 | Author: lissawillem | Posted in Other Health
Print Email More
Cancer the most familiar and known term nowadays but unfortunately its treatment is not familiar and known with scientist in specific and people in general. Every year millions of peoples comes under its trap. Thousands of people die just because there is no full prove successful treatment is available. Discovering full prove drug for cancer is mystery and unavailability of the drug for cancer is nightmare for people. Scientist through out the ages is baffling with the term cancer. A lot of discovery is made but not entirely curable drug ever came up in pharmaceutical industry. Scientist is trying their level best to decode the deadly disease. A considerable number of drugs are been invented to combat the disease.
Cancer is caused due to unwanted and uncontrolled growth of enzyme called protein kinase. Researchers and scientist recently discovered inhibitor for this deadly enzyme. This is called kinase inhibitor. Kinase is responsible for causing cancer. This kinase inhibitor is a type of protein enzyme drug. This kinase inhibitor acts on kinase there by hindering the further growth of kinase. Kinase inhibitor is bimolecular which slower the activity of kinase or even alter the pattern of kinase function. Reaction of this kinase inhibitor varies from patients to patients.
A lot of kinase drug is been invented, some are already operating in the market while other are still in the queue of their due clinical trail Among the most successful kinase inhibitor are Tacotinib,ACC200, Tivozanib AT-7519 and many more in the bandwagon. Tivozanib is new drug, which act as kinase inhibitor. It is bimolecular orally given to patients of cancer. It belongs to the category of urine quinoline. It works on patients with renal cell carcinoma. It is the drug to block the vascular endothelial growth factors pathway. Tizonabin blocks all the three pathway of VEGF that is VEGF 1, VEGF 2,VEGF 3.Tinozibin Detroit angiogenesis, which is the formation of new blood, cell. Due to this uncontrolled and unwanted formation of blood cell cancer patients die. Tivozanib put a check on angeniosis by blocking all the pathway of the three receptors of VEGF.
ACC200 is also very successful kinase inhibitor which is used fro the treatment of acute myeloid leukemia. Leukemia is a type of cancer where the white blood cell grows randomly altering the normal genetic setting of the infected person. Leukemia is fatal in the sense that the infected patient loss the immunity. It lost the fighting capacity of the body from infection. Even a minute injury cause uncontrolled flow of blood.
Tasotinib is also a very successful anti cancer drug. Tacotanib is orally given to cancer patients as pills. It is anti-rheumatic drug, which brings some relief to patients with rheumatic disease. In recent time this tasotinib kinase inhibitor has proved fruitful in treating cancer. Similarly AT-7519 is also an inhibitor of kinase. This drug is queue for its clinical trail. This has also acted successfully on inhibiting kinase .AT 7519 has scientifically proven a huge inhibitor of tumor growth. Another very ongoing kinase inhibitor nowadays used in pharmaceuticals industry is SU 5402. This drug is used widely to combat kinase enzyme. This kinase inhibitor does inhibit activity of kinase in some receptors like kinase activity of fibroblast growth factor receptor while SU 5402 is weak inhibitor of tyrosine phosphorylation receptor.
Science has advanced to a larger extent. It has cure to even most deadly disease but unfortunately it has not come up till date to fully decode the disease called cancer. A lot of fruitful drugs are discovered to slow down the process of cancer or to inhibit it from further damaging the patient but nothing has ever discovered to fully get away from this deadliest disease. It is the nature of humane to be hopeful and aspire for the excellence. All the above drugs do give some relief to cancer patients and an endless research in going on to fully defeat the disease.

Cancer the most familiar and known term nowadays but unfortunately its treatment is not familiar and known with scientist in specific and people in general. Every year millions of peoples comes under its trap. Thousands of people die just because there is no full prove successful treatment is available. Discovering full prove drug for cancer is mystery and unavailability of the drug for cancer is nightmare for people. Scientist through out the ages is baffling with the term cancer. A lot of discovery is made but not entirely curable drug ever came up in pharmaceutical industry. Scientist is trying their level best to decode the deadly disease. A considerable number of drugs are been invented to combat the disease.
Cancer is caused due to unwanted and uncontrolled growth of enzyme called protein kinase. Researchers and scientist recently discovered inhibitor for this deadly enzyme. This is called kinase inhibitor. Kinase is responsible for causing cancer. This kinase inhibitor is a type of protein enzyme drug. This kinase inhibitor acts on kinase there by hindering the further growth of kinase. Kinase inhibitor is bimolecular which slower the activity of kinase or even alter the pattern of kinase function. Reaction of this kinase inhibitor varies from patients to patients.
A lot of kinase drug is been invented, some are already operating in the market while other are still in the queue of their due clinical trail Among the most successful kinase inhibitor are Tacotinib,ACC200, Tivozanib AT-7519 and many more in the bandwagon. Tivozanib is new drug, which act as kinase inhibitor. It is bimolecular orally given to patients of cancer. It belongs to the category of urine quinoline. It works on patients with renal cell carcinoma. It is the drug to block the vascular endothelial growth factors pathway. Tizonabin blocks all the three pathway of VEGF that is VEGF 1, VEGF 2,VEGF 3.Tinozibin Detroit angiogenesis, which is the formation of new blood, cell. Due to this uncontrolled and unwanted formation of blood cell cancer patients die. Tivozanib put a check on angeniosis by blocking all the pathway of the three receptors of VEGF.
ACC200 is also very successful kinase inhibitor which is used fro the treatment of acute myeloid leukemia. Leukemia is a type of cancer where the white blood cell grows randomly altering the normal genetic setting of the infected person. Leukemia is fatal in the sense that the infected patient loss the immunity. It lost the fighting capacity of the body from infection. Even a minute injury cause uncontrolled flow of blood.

Tasotinib is also a very successful anti cancer drug. Tacotanib is orally given to cancer patients as pills. It is anti-rheumatic drug, which brings some relief to patients with rheumatic disease. In recent time this tasotinib kinase inhibitor has proved fruitful in treating cancer. Similarly AT-7519 is also an inhibitor of kinase. This drug is queue for its clinical trail. This has also acted successfully on inhibiting kinase .AT 7519 has scientifically proven a huge inhibitor of tumor growth. Another very ongoing kinase inhibitor nowadays used in pharmaceuticals industry is SU 5402. This drug is used widely to combat kinase enzyme. This kinase inhibitor does inhibit activity of kinase in some receptors like kinase activity of fibroblast growth factor receptor while SU 5402 is weak inhibitor of tyrosine phosphorylation receptor.
Science has advanced to a larger extent. It has cure to even most deadly disease but unfortunately it has not come up till date to fully decode the disease called cancer. A lot of fruitful drugs are discovered to slow down the process of cancer or to inhibit it from further damaging the patient but nothing has ever discovered to fully get away from this deadliest disease. It is the nature of humane to be hopeful and aspire for the excellence. All the above drugs do give some relief to cancer patients and an endless research in going on to fully defeat the disease.

Processing your request, Please wait....

Additional Articles From "Other Health"